Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;26(1):374-383.
doi: 10.1093/cercor/bhu291. Epub 2014 Dec 22.

Prenatal Exposure to Autism-Specific Maternal Autoantibodies Alters Proliferation of Cortical Neural Precursor Cells, Enlarges Brain, and Increases Neuronal Size in Adult Animals

Affiliations

Prenatal Exposure to Autism-Specific Maternal Autoantibodies Alters Proliferation of Cortical Neural Precursor Cells, Enlarges Brain, and Increases Neuronal Size in Adult Animals

Verónica Martínez-Cerdeño et al. Cereb Cortex. 2016 Jan.

Abstract

Autism spectrum disorders (ASDs) affect up to 1 in 68 children. Autism-specific autoantibodies directed against fetal brain proteins have been found exclusively in a subpopulation of mothers whose children were diagnosed with ASD or maternal autoantibody-related autism. We tested the impact of autoantibodies on brain development in mice by transferring human antigen-specific IgG directly into the cerebral ventricles of embryonic mice during cortical neurogenesis. We show that autoantibodies recognize radial glial cells during development. We also show that prenatal exposure to autism-specific maternal autoantibodies increased stem cell proliferation in the subventricular zone (SVZ) of the embryonic neocortex, increased adult brain size and weight, and increased the size of adult cortical neurons. We propose that prenatal exposure to autism-specific maternal autoantibodies directly affects radial glial cell development and presents a viable pathologic mechanism for the maternal autoantibody-related prenatal ASD risk factor.

Keywords: autism; brain size; maternal autoantibody; neurogenesis; radial glial cells.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Biotinylated-MARab or MTDab were injected into the cerebral ventricles of E14 embryonic mice. (A,B) Coronal sections run in parallel for biotin amplification showed biotin-MARab-labeled cells in the VZ and SVZ (A), whereas biotin-MTDab did not label cells (B). Note: erythrocytes produced nonspecific labeling in MARab and MTDab. (CG) RG neural stem cells were positive for biotin-MARab. Arrowheads indicate RG pial fibers; arrows indicate RG ventricular process. (H,I) biotin-MARab+ cells (green) co-localized with the RG cell marker vimentin (red). Scale bars: (A,B) 100 µm; (CH) 10 µm.
Figure 2.
Figure 2.
Analysis of precursor cell number. Maternal MAUab and MTDab IgGs were injected in utero in E14 mice, and precursor cell number in the cerebral cortex was quantified 2 days later at E16. (A) Triple immunostaining for Pax6 (red, B), Tbr2 (green, C), and 4A4 (blue, D). (E) Proliferative precursor cell types located in the SVZ of the E16 developing cortex. Inset indicates region of higher power images to the right. Mitotic translocating RG cells were identified by expression of the mitotic cell marker 4A4 (red), presence of a pial directed fiber, and expression of Pax6 (green). (F) Proliferative precursor cell types in the E16 developing cortex. Inset indicates region of higher power images to the right. Mitotic intermediate progenitor cells were identified by expression of the mitotic cell marker 4A4 (red), and expression of Tbr2 located in the SVZ (green). Calibration bar: (AD) 250 µm; (E,F) 100 µm and 25 µm, respectively.
Figure 3.
Figure 3.
Prenatal exposure to MAUab increases the number of proliferative Pax6+ precursor cells in the SVZ. Maternal MAUab and MTDab IgGs were injected in utero in E14 mice, and precursor cell number in the cerebral cortex was quantified 2 days later at E16. (A,B,G) MAUab treatment increased the number of 4A4+ mitotic precursor cells in the SVZ (P = 0.02), but not in the VZ of the developing neocortex. (C–F, H,I) The total number of Tbr2+ and Pax6+ precursor cells did not differ in mice exposed to MAUab compared with mice exposed to MTDab. (J) The number of mitotic Tbr2+ precursor cells (Tbr2+/4A4+) was not differentness in mice exposed to MAUab versus MTDab. However, the number of mitotic Pax6+ precursor cells (Pax6+/4A4+) was significantly increased in the SVZ (P = 0.01), but not in the VZ of the developing neocortex of mice exposed to MAUab versus MTDab. Calibration bar: 50 µm.
Figure 4.
Figure 4.
MAUab treatment significantly increased the number of mitotic precursor cells in the SVZ of the ganglionic eminence. (A,B) E16 murine ganglionic eminence (GE) 2 days after injection with either MAUab and MTDab IgGs at E14. (C) The number of 4A4+ mitotic precursor cells was significantly increased in the SVZ (P = 0.03), but not in the VZ of the developing GE after exposure to MAUab compared with MTDab exposure. Calibration bar: 100 µm.
Figure 5.
Figure 5.
Prenatal MAUab exposure increased brain size and weight. (A) Brains of adult animals prenatally exposed to MAUab weighed more than those exposed to MTDab (MAUab: 365.26 ± 5.06 mg; MTDab: 352.73 ± 2.41 mg; P = 0.002). (B,C) Rostro-caudal length (R-C) was increased in brains from animals exposed to MAUab compared with those exposed to MTDab. Medio-lateral length (M-L) was increased but the difference was not a significant.
Figure 6.
Figure 6.
Stereological analysis of cortical cell number and somal size in the adult cerebral cortex of animals that were prenatally exposed to MAUab or MTDab at E14. (A,B) The number of Neu+ cells (neurons), S100+ cells (astrocytes), and Olig2+ cells (oligodendrocytes) did not differ between MAUab and MTDab mice. (C) However, the size of the NeuN+ cells was increased in the MAUab-exposed animals compared with those exposed to MTDab (P = 0.01). Calibration bar: (AD). 100 µm.
Figure 7.
Figure 7.
Scheme depicting how prenatal MAUab impacts precursor cell function during development of the cerebral cortex. RG cells detach from the ventricle and translocate their soma from the VZ into the overlying SVZ. However, the stage of development at which RG cells translocate into the SVZ is tightly regulated and varies by species. (A) In mouse, Pax6+ RG cells begin translocating from the VZ during later stages of neurogenesis. (B) In macaque, RG cells begin translocating into the SVZ soon after the start of neurogenesis. (C) In the prenatal mouse neocortex that has been exposed to MAUab, RG cells precociously detach from the ventricle and translocate away from the VZ into the SVZ much earlier than normal. Prenatal treatment with MAUab produces RG translocation in the mouse at nearly the same stage of cortical development as occurs in the macaque, changing the normal pattern and timing of the neurogenic process.

Similar articles

Cited by

References

    1. Alayev A, Holz MK. 2013. mTOR signaling for biological control and cancer. J Cell Physiol. 228(8):1658–1664. - PMC - PubMed
    1. American Psychiatric Association D. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed Washington, DC.
    1. Arantes C, Nomizo R, Lopes MH, Hajj GN, Lima FR, Martins VR. 2009. Prion protein and its ligand stress inducible protein 1 regulate astrocyte development. Glia. 57(13):1439–1449. - PubMed
    1. Bauman MD, Iosif AM, Ashwood P, Braunschweig D, Lee A, Schumann CM, Van de Water J, Amaral DG. 2013. Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey. Transl Psychiatry. 3:e278. - PMC - PubMed
    1. Bothwell S, Meredith GE, Phillips J, Staunton H, Doherty C, Grigorenko E, Glazier S, Deadwyler SA, O'Donovan CA, Farrell M. 2001. Neuronal hypertrophy in the neocortex of patients with temporal lobe epilepsy. J Neurosci. 21(13):4789–4800. - PMC - PubMed

Publication types